Trial Profile
Open-label, randomized multicentre, phase II trial of Oral vinorelbine (NVBo) or intravenous vinorelbine (NVBiv) with cisplatin (CDDP) in patients (pts) with advanced Non Small Cell Lung Cancer (NSCLC): A Chinese experience (CA225 study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2014
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary) ; Vinorelbine (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Jul 2011 New trial record
- 07 Jul 2011 Results presented at the 14th World Conference on Lung Cancer.